E. Calabrese, “The Gofman-Tamplin Cancer Risk Controversy and Its Impact on the Creation of BEIR I and the Acceptance of LNT”, Med Lav, vol. 114, no. 1, p. e2023007, Feb. 2023, doi: 10.23749/mdl.v114i1.14006.